Aleafia Health Announces Successful Bids in Sale and Investment Solicitation Process
TORONTO, Oct. 12, 2023 (GLOBE NEWSWIRE) — Aleafia Health Inc. (“Aleafia” or the “Corporation”) announces that Red White & Bloom Brands Inc. (“RWB”) has been selected as the successful bidder pursuant to the Court-approved sale and investment solicitation process (the “SISP”) in connection with the previously announced proceedings of Aleafia and certain of its subsidiaries under […]
Read Press ReleaseAleafia Health Obtains Creditor Protection to Pursue Restructuring and Sale Process
TORONTO, July 25, 2023 – Aleafia Health Inc. (TSX:AH, OTCQB:ALEAF) (“Aleafia” or the “Corporation”) announces today that the Corporation and certain of its Canadian subsidiaries, Emblem Corp., Emblem Cannabis Corporation, Emblem Realty Ltd., Growwise Health Limited, Canabo Medical Corporation, Aleafia Inc., Aleafia Farms Inc., Aleafia Brands Inc., Aleafia Retail Inc., 2672533 Ontario Inc., and 2676063 […]
Read Press ReleaseRed White & Bloom and Aleafia Health Mutually Agree to Terminate Binding Letter Agreement
TORONTO, ONTARIO July 14, 2023 (GLOBE NEWSWIRE) – Red White & Bloom Brands Inc. (CSE: RWB and OTC: RWBYF) (“RWB” or the “Company”) and Aleafia Health Inc. (TSX: AH and OTCQB: ALEAF) (“Aleafia”) are announcing the mutual termination of the binding letter agreement entered into between the parties on June 6, 2023 (the “Letter Agreement”) in […]
Read Press ReleaseAleafia Health Announces Fourth Quarter and Annual Financial Results
Revenue increased 9% to $11.7 million for the period ended March 31, 2023 (“Q4 FY2023”) versus $10.7 million for the period ended March 31, 2022 Net revenue increased 33% to $9.4 million for Q4 FY2023 versus $7.0 million for the period ended March 31, 2022 Revenue increased 24% to $57.4 million for the 12 months […]
Read Press ReleaseRed White & Bloom and Aleafia Health Execute Binding Letter Agreement for Business Combination
The Combined Company (as defined below) is expected to represent C$138 million in trailing distribution and retail revenue from the Canadian, United States and European cannabis end-markets and combined Gross Profit before fair value adjustments of $39 million.(1)(2)(3)(4) On a combined basis, RWB and Aleafia are expected to service approximately 3,000 retail locations in North […]
Read Press ReleaseAleafia Health Announces Extension of Forbearance Under Loan Agreement with Senior Lender
TORONTO, June 1, 2023 – Aleafia Health Inc. (TSX: AH, OTCQB: ALEAF) (“Aleafia Health” or the “Company”) announces that the Company has entered into a forbearance agreement with NE SPC II LP (“NE SPC”) extending the forbearance period under its loan agreement with NE SPC until June 5, 2023. The forbearance agreement comes in light […]
Read Press ReleaseAleafia Health Announces Amendment to Credit Facility and Strategic Review Process
TORONTO, May 25, 2023 – Aleafia Health Inc. (TSX: AH, OTCQB: ALEAF) (“Aleafia Health” or the “Company”) announces that the Company has entered into an amendment to the terms of the loan agreement with NE SPC II LP (“NE SPC”) dated as of December 24, 2021 and as previously amended by agreements dated March 28, […]
Read Press ReleaseAleafia Health Announces Q3 FY2023 Results, International Expansion and Second Quarter of Profitability
2nd consecutive quarter of positive Adjusted EBITDA[1] 4% Adjusted EBITDA margin[2] places company in top 3 position for profitability amongst its peers[3] 9% growth in adult use revenue[4] over prior quarter; 5% growth in adult-use revenue[5] year over year 40% increase in medical net revenue[6] with $1.1 million record month revenue in November 2022 1st […]
Read Press ReleaseAleafia Health to Announce Fiscal Year 2023 Third Quarter Results
TORONTO, February 7, 2023 – Aleafia Health Inc. (TSX: AH, OTCQB: ALEAF) (“Aleafia Health” or the “Company”) will now announce on Monday, February 13 prior to market open its fiscal year 2023 third quarter results for the period ending December 31, 2022. The Company will also host its earnings conference call the same day at […]
Read Press ReleaseAleafia Health to Announce Fiscal Year 2023 Third Quarter Results
TORONTO, February 1, 2023 – Aleafia Health Inc. (TSX: AH, OTCQB: ALEAF) (“Aleafia Health” or the “Company”) will announce on February 8 prior to market open its fiscal year 2023 third quarter results for the period ending December 31, 2022. The Company will also host its earnings conference call the same day at 8:30 a.m. […]
Read Press ReleaseAleafia Health Announces New International Partner, Strengthening Connections in High-Potential European Market, New Board Chair Also Named
TORONTO, January 30, 2023 – Aleafia Health Inc. (TSX: AH, OTCQB: ALEAF) (“Aleafia Health” or the “Company”) is pleased to announce that it has signed a new European cannabis distribution partner, representing a one-year, approximately $1 million contract[1], significantly bolstering the Company’s record $1.2 million year-to-date sales in its growing international channel. “This new announcement […]
Read Press ReleaseAleafia Health Successfully Completes TSX Review and Announces Entry into Fifth Province
Successful completion of TSX listing review Expansion of adult-use portfolio into key fifth province 5 provinces now selling Aleafia’s adult-use products TORONTO, November 28, 2022 – Further to its previous announcements, Aleafia Health Inc. (TSX: AH, OTCQB: ALEAF) (“Aleafia Health” or the “Company”) is pleased to announce that it has completed the TSX delisting review […]
Read Press ReleaseAleafia Health Announces Achieving Major Profitability Milestone Ahead of Target and $10.6 Million Total Net Revenue in Q2 FY2023
Adjusted EBITDA[1] profitability achieved in Q2 FY2023, ahead of plan 21% increase in total revenue year over year to $14.5 23% increase in branded cannabis net revenue[2] year over year to $9.4 million #3 ranking in total retail sales pull through growth among 20 top Canadian LPs[3] #2 milled and #4 pre-roll market share ranking […]
Read Press ReleaseAleafia Health to Announce Fiscal Year 2023 Second Quarter Results
TORONTO, November 2, 2022 – Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”) will announce on November 9 prior to market open its fiscal year 2023 second quarter results for the period ending September 30, 2022. The Company will also host its earnings conference call the same day at 8:30 a.m. […]
Read Press ReleaseAleafia Health Expands Sunday Market House of Brands With Coveted Lineup of Winter Product Launches
16 total new listings added to the Sunday Market portfolio by February 2023 9 new Divvy products in profitable flower, vape, and milled categories Kin Slips portfolio expands to include the California brand’s best-selling CBN product Shut Eye Plus CBD-forward brand Noon & Night extends giftable CBD product lineup Innovative Bogart’s Kitchen portfolio adds to […]
Read Press Release